Chemed (NYSE:CHE) EVP Spencer Lee Sells 1,000 Shares of Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $547.61, for a total value of $547,610.00. Following the completion of the transaction, the executive vice president directly owned 12,931 shares of the company’s stock, valued at approximately $7,081,144.91. This trade represents a 7.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Chemed Stock Performance

Shares of CHE stock traded down $0.84 during mid-day trading on Friday, reaching $549.36. The stock had a trading volume of 73,522 shares, compared to its average volume of 159,157. Chemed Corporation has a one year low of $365.20 and a one year high of $562.24. The firm has a market cap of $7.15 billion, a PE ratio of 26.28, a P/E/G ratio of 2.09 and a beta of 0.50. The firm’s 50 day simple moving average is $516.95 and its 200 day simple moving average is $467.59. The company has a quick ratio of 1.08, a current ratio of 1.11 and a debt-to-equity ratio of 0.27.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, October 27th. The company reported $6.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.44 by $0.31. The business had revenue of $690.94 million for the quarter, compared to analysts’ expectations of $685.04 million. Chemed had a return on equity of 35.18% and a net margin of 10.61%. Chemed’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the business posted $5.27 earnings per share. On average, analysts forecast that Chemed Corporation will post 24.05 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Monday, November 16th will be paid a $0.70 dividend. The ex-dividend date is Monday, November 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is currently 13.40%.

Analyst Ratings Changes

Several brokerages have recently weighed in on CHE. UBS Group lifted their target price on shares of Chemed from $650.00 to $675.00 and gave the company a “buy” rating in a research report on Thursday, October 29th. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and increased their price target for the stock from $520.00 to $620.00 in a research report on Wednesday, October 28th. Oppenheimer raised their price target on shares of Chemed from $590.00 to $625.00 and gave the stock an “outperform” rating in a research note on Thursday, October 29th. Weiss Ratings upgraded shares of Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Finally, Wall Street Zen raised Chemed from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 10th. Three analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $603.00.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Jump Financial LLC acquired a new stake in shares of Chemed in the 3rd quarter valued at $493,000. EP Wealth Advisors LLC grew its holdings in shares of Chemed by 16.5% in the 3rd quarter. EP Wealth Advisors LLC now owns 750 shares of the company’s stock worth $379,000 after purchasing an additional 106 shares during the last quarter. Pathstone Holdings LLC grew its holdings in shares of Chemed by 6.4% in the 3rd quarter. Pathstone Holdings LLC now owns 5,535 shares of the company’s stock worth $2,795,000 after purchasing an additional 334 shares during the last quarter. Caxton Associates LLP increased its position in shares of Chemed by 26.8% during the 3rd quarter. Caxton Associates LLP now owns 7,102 shares of the company’s stock worth $3,587,000 after purchasing an additional 1,501 shares in the last quarter. Finally, Gamco Investors INC. ET AL increased its position in shares of Chemed by 0.9% during the 3rd quarter. Gamco Investors INC. ET AL now owns 20,713 shares of the company’s stock worth $10,462,000 after purchasing an additional 185 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.